Analyse comparative de la survie des mélanomes muqueux et cutanés traités par inhibiteurs de checkpoint immunitaires en première ligne thérapeutique
S. Tzoumpa, E. Maubec, P. Celérier(Centre Hospitalier de La Rochelle), N. Beneton, M. Amini-Adle, E. Funck-Brentano, L. Mortier, J. De Quatrebarbes, G. Jeudy, J. Lavaud, F. Brunet Possenti, Alain Dupuy, A. Khammari, M.T. Leccia, L. Misery, C. Gaudy-Marqueste, C. Lesage, Sébastien Colin, G. Quéreux, F. Grange, Y. Le Corre, C. Nardin, C. Bejar, N. Litrowski, T. Jouary, H. Montaudié, A.-B. Duval-Modeste(Inserm), Z. Julia, R. Vernet, D. Legoupil, O. Zehou, N. Leduc, Alice Hervieu
Cited by 0
Related Papers
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
|Annals of the Rheumatic Diseases|2012|207
Prospective Multicenter Study of Pegylated Liposomal Doxorubicin Treatment in Patients With Advanced or Refractory Mycosis Fungoides or Sézary Syndrome
|Archives of Dermatology|2008|103
GENIPSO: a French prospective study assessing instantaneous prevalence, clinical features and impact on quality of life of genital psoriasis among patients consulting for psoriasis
|British Journal of Dermatology|2018|84
Management and outcome of metastatic melanoma during pregnancy
|British Journal of Dermatology|2009|71
Modulatory effects of selenium and strontium salts on keratinocyte-derived inflammatory cytokines
|Archives of Dermatological Research|1995|66